AMLo Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- AMLo Biosciences's estimated annual revenue is currently $1.7M per year.
- AMLo Biosciences's estimated revenue per employee is $77,500
Employee Data
- AMLo Biosciences has 22 Employees.
- AMLo Biosciences grew their employee count by 83% last year.
AMLo Biosciences's People
| Name | Title | Email/Phone |
|---|
AMLo Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.7M | 22 | 83% | N/A | N/A |
What Is AMLo Biosciences?
Formed in late 2017, AMLo Biosciences is dedicated to providing a prognostic test for early AJCC Stage I and Stage II melanoma to better identify patients’ true risk of disease progression. Those patients who are genuinely at low-risk of disease spread can be provided reassurance and better-informed follow-up care, while those identified at risk of metastasis are enabled to receive timely treatment. The test under development – AMBLor® – will be simple to use and fits seamlessly into current diagnostic practice. AMLo Biosciences has been founded by a team with an internationally acclaimed research track record in the melanoma field, through identification of translational biomarkers, drug discovery & development and the building of biotech companies.
keywords:N/A
N/A
Total Funding
22
Number of Employees
$1.7M
Revenue (est)
83%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Newcastle upon Tyne
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.9M | 24 | -4% | N/A |
#2 | N/A | 31 | 94% | N/A |
#3 | N/A | 39 | -5% | N/A |
#4 | $6.8M | 44 | 42% | N/A |
#5 | N/A | 44 | 33% | N/A |